ABSENT CD33 IN AML PATIENTS: FROM DIAGNOSIS TO FOLLOW-UPS
Leticia O. Marania, Amanda Costaa,b, Fernanda B. Silvaa, Maria Izabel A. Madeiraa, Priscila S. Scheuchera, Josiane L.S. Schiavinatoa, Ana Silvia G. Limaa, Katia B.B. Pagnanoc, Bruno K. Duartec, Sylvie Freemand, Eduardo M. Regoe, Fabiola Trainaa, Lorena L. Figueiredo-Pontesa
a Divisão de Hematologia, Departamento de Imagens Médicas, Hematologia e Oncologia Clínica, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brazil
b Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, United States of America
c Hemocentro, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
d Institute of Immunology and Immunotherapy, University of Birmingham, Birminham, United Kingdom
e Medicina Interna, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
Read
1318
Timeswas read the article
605
Total PDF
713
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 7 | 12 |
| 2025 5 | 49 | 13 | 62 |
| 2025 4 | 37 | 23 | 60 |
| 2025 3 | 52 | 15 | 67 |
| 2025 2 | 42 | 19 | 61 |
| 2025 1 | 29 | 20 | 49 |
| 2024 12 | 18 | 17 | 35 |
| 2024 11 | 32 | 21 | 53 |
| 2024 10 | 24 | 20 | 44 |
| 2024 9 | 44 | 22 | 66 |
| 2024 8 | 48 | 36 | 84 |
| 2024 7 | 35 | 18 | 53 |
| 2024 6 | 37 | 34 | 71 |
| 2024 5 | 32 | 22 | 54 |
| 2024 4 | 25 | 17 | 42 |
| 2024 3 | 25 | 21 | 46 |
| 2024 2 | 13 | 28 | 41 |
| 2024 1 | 13 | 14 | 27 |
| 2023 12 | 14 | 32 | 46 |
| 2023 11 | 25 | 42 | 67 |
| 2023 10 | 19 | 31 | 50 |
| 2023 9 | 19 | 25 | 44 |
| 2023 8 | 10 | 19 | 29 |
| 2023 7 | 16 | 7 | 23 |
| 2023 6 | 20 | 24 | 44 |
| 2023 5 | 17 | 28 | 45 |
| 2023 4 | 13 | 30 | 43 |
Show all
